Fassio, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 2.305
EU - Europa 2.297
AS - Asia 1.112
AF - Africa 39
SA - Sud America 22
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.786
Nazione #
US - Stati Uniti d'America 2.291
CN - Cina 791
GB - Regno Unito 508
DE - Germania 333
IT - Italia 331
IE - Irlanda 250
SE - Svezia 249
RU - Federazione Russa 232
FR - Francia 211
SG - Singapore 160
FI - Finlandia 73
JP - Giappone 48
UA - Ucraina 35
VN - Vietnam 30
TG - Togo 27
KR - Corea 20
NL - Olanda 16
CA - Canada 14
HK - Hong Kong 14
BR - Brasile 13
AT - Austria 9
BE - Belgio 9
RO - Romania 9
IR - Iran 8
TR - Turchia 8
AU - Australia 7
CH - Svizzera 6
IN - India 6
PT - Portogallo 6
EG - Egitto 5
QA - Qatar 5
CZ - Repubblica Ceca 4
ES - Italia 4
IQ - Iraq 4
PK - Pakistan 4
ZA - Sudafrica 4
AR - Argentina 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
EC - Ecuador 2
HR - Croazia 2
ID - Indonesia 2
SI - Slovenia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.786
Città #
Chandler 609
Southend 484
Dublin 245
Ashburn 191
Beijing 149
Jacksonville 130
Singapore 112
Redmond 97
Princeton 84
Lawrence 83
Wilmington 78
New York 75
Verona 64
Ann Arbor 62
Jinan 59
Shenyang 55
Helsinki 54
Woodbridge 52
Houston 50
Nanjing 46
Tokyo 46
Bologna 43
Sindelfingen 39
Hebei 34
Tianjin 32
Zhengzhou 29
Haikou 27
Lomé 27
Washington 26
San Francisco 25
Changsha 24
Hangzhou 23
Ningbo 20
Seattle 20
Fairfield 15
Jiaxing 15
Redwood City 15
Rome 15
Taiyuan 15
Dallas 14
Los Angeles 14
Dong Ket 13
Milan 13
Nanchang 13
Seoul 13
Taizhou 13
Chicago 12
Guangzhou 12
Norwalk 11
Nürnberg 10
Brussels 9
Vienna 9
Falls Church 8
Florianópolis 8
Bârlad 7
Dearborn 7
Dongguan 7
Düsseldorf 7
Hong Kong 7
Lanzhou 7
Amsterdam 6
Boydton 6
Detroit 6
Fuzhou 6
Kent 6
Seo-gu 6
Toronto 6
Des Moines 5
Esslingen am Neckar 5
Falkenstein 5
London 5
Romola 5
Bari 4
Cagliari 4
Easton 4
Miami 4
Shanghai 4
Trieste 4
Zurich 4
Biandronno 3
Canberra 3
Central 3
Faenza 3
Frankfurt am Main 3
Genova 3
Kemerovo 3
Lancaster 3
Las Vegas 3
Madrid 3
Mansehra 3
Mehlingen 3
Moscow 3
Ottawa 3
Riva 3
Saint-Etienne 3
São Paulo 3
Tarcento 3
Venice 3
Zanjan 3
Acquaviva Picena 2
Totale 3.640
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 246
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 117
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 116
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 109
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 108
Anti-CCP antibodies and bone 100
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 99
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 97
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 95
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 93
Periostin: The bone and beyond 92
Drug-induced osteonecrosis of the jaw: the state of the art 88
Duration of treatment for osteoporosis 88
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 87
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 87
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 86
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 86
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 85
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 84
Rheumatoid arthritis, γδ T cells and bisphosphonates 82
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 81
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 80
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 80
The obesity paradox and osteoporosis 76
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 71
Effects of secukinumab on serum adipocytokines: preliminary data 70
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 69
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 69
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 69
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 69
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 68
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 68
Vitamin D: not just bone, but also immunity 67
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 67
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 67
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 67
Association between environmental air pollution and rheumatoid arthritis flares 67
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 63
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 63
Correction to: The obesity paradox and osteoporosis 62
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 62
Insight into the WNT system and its drug related response. 61
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 59
Wnt pathway involvement and its response to treatment in the development of bone damage in different inflammatory and non-inflammatory rheumatic contidions 59
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 58
Osteoporosis in Rheumatic Diseases 58
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 57
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 56
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 56
Radiological features of knee joint synovial chondromatosis 52
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 52
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 52
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 51
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 51
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 50
Calcium and vitamin D supplementation: when and why 50
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 50
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 49
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 48
Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus 48
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 48
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 47
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 47
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 46
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 45
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 45
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 44
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 44
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 44
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 43
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 42
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 42
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 41
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 40
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 40
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review 38
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 37
Ultrasonographic detection, definition and quantification of soft tissue oedema in psoriatic dactylitis 37
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 37
Pharmacological management of osteoporosis in postmenopausal women: The current state of the art 36
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 34
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 33
Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) 31
Vitamin D and Osteogenesis Imperfecta in Pediatrics 29
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 28
Association between acute exposure to environmental air pollution and fragility hip fractures 28
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 28
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 26
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 24
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 24
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 22
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 22
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 21
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 21
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 20
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 19
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 17
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting 17
Bone health status evaluation in men by means of REMS technology 17
Discontinuation of infliximab leading to auditory loss in a patient with Cogan syndrome: A case report 17
Totale 5.838
Categoria #
all - tutte 26.228
article - articoli 25.624
book - libri 0
conference - conferenze 341
curatela - curatele 0
other - altro 263
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020400 0 0 0 51 54 66 53 8 42 34 30 62
2020/2021717 105 120 26 118 76 50 42 5 52 8 64 51
2021/2022692 62 164 12 43 23 23 19 31 54 24 36 201
2022/20231.724 98 175 142 329 157 400 17 87 206 28 66 19
2023/20241.120 37 89 101 124 110 220 60 59 30 63 171 56
2024/2025483 114 127 126 116 0 0 0 0 0 0 0 0
Totale 6.003